These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 9858524

  • 1. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells.
    Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B.
    J Exp Med; 1998 Dec 21; 188(12):2375-80. PubMed ID: 9858524
    [Abstract] [Full Text] [Related]

  • 2. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
    Mirandola P, Ponti C, Gobbi G, Sponzilli I, Vaccarezza M, Cocco L, Zauli G, Secchiero P, Manzoli FA, Vitale M.
    Blood; 2004 Oct 15; 104(8):2418-24. PubMed ID: 15205263
    [Abstract] [Full Text] [Related]

  • 3. Characteristics of the killing mechanism of human natural killer cells against hepatocellular carcinoma cell lines HepG2 and Hep3B.
    Kim HR, Park HJ, Park JH, Kim SJ, Kim K, Kim J.
    Cancer Immunol Immunother; 2004 May 15; 53(5):461-70. PubMed ID: 14648068
    [Abstract] [Full Text] [Related]

  • 4. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
    Kashii Y, Giorda R, Herberman RB, Whiteside TL, Vujanovic NL.
    J Immunol; 1999 Nov 15; 163(10):5358-66. PubMed ID: 10553060
    [Abstract] [Full Text] [Related]

  • 5. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C, Mukhopadhyay S, Kovacs E, Medina R, Patel P, Catina TL, Campbell KS, Santoli D.
    J Leukoc Biol; 2005 Aug 15; 78(2):359-71. PubMed ID: 15937142
    [Abstract] [Full Text] [Related]

  • 6. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts.
    Taylor MA, Ward B, Schatzle JD, Bennett M.
    Eur J Immunol; 2002 Mar 15; 32(3):793-9. PubMed ID: 11870623
    [Abstract] [Full Text] [Related]

  • 7. TRAIL, FasL and a blocking anti-DR5 antibody augment paclitaxel-induced apoptosis in human non-small-cell lung cancer.
    Odoux C, Albers A, Amoscato AA, Lotze MT, Wong MK.
    Int J Cancer; 2002 Feb 01; 97(4):458-65. PubMed ID: 11802207
    [Abstract] [Full Text] [Related]

  • 8. Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells.
    Choi C, Kutsch O, Park J, Zhou T, Seol DW, Benveniste EN.
    Mol Cell Biol; 2002 Feb 01; 22(3):724-36. PubMed ID: 11784850
    [Abstract] [Full Text] [Related]

  • 9. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
    Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H.
    J Immunol; 1999 Aug 15; 163(4):1906-13. PubMed ID: 10438925
    [Abstract] [Full Text] [Related]

  • 10. Regulation of APO-2 ligand/trail expression in NK cells-involvement in NK cell-mediated cytotoxicity.
    Johnsen AC, Haux J, Steinkjer B, Nonstad U, Egeberg K, Sundan A, Ashkenazi A, Espevik T.
    Cytokine; 1999 Sep 15; 11(9):664-72. PubMed ID: 10479402
    [Abstract] [Full Text] [Related]

  • 11. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.
    Uno K, Inukai T, Kayagaki N, Goi K, Sato H, Nemoto A, Takahashi K, Kagami K, Yamaguchi N, Yagita H, Okumura K, Koyama-Okazaki T, Suzuki T, Sugita K, Nakazawa S.
    Blood; 2003 May 01; 101(9):3658-67. PubMed ID: 12506034
    [Abstract] [Full Text] [Related]

  • 12. Fas-associated death domain protein (FADD) and caspase-8 mediate up-regulation of c-Fos by Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via a FLICE inhibitory protein (FLIP)-regulated pathway.
    Siegmund D, Mauri D, Peters N, Juo P, Thome M, Reichwein M, Blenis J, Scheurich P, Tschopp J, Wajant H.
    J Biol Chem; 2001 Aug 31; 276(35):32585-90. PubMed ID: 11384965
    [Abstract] [Full Text] [Related]

  • 13. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N, Poulaki V, Tseleni-Balafouta S, Koutras DA, Stamenkovic I.
    Cancer Res; 2000 Aug 01; 60(15):4122-9. PubMed ID: 10945619
    [Abstract] [Full Text] [Related]

  • 14. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death.
    Ibrahim SM, Ringel J, Schmidt C, Ringel B, Müller P, Koczan D, Thiesen HJ, Löhr M.
    Pancreas; 2001 Jul 01; 23(1):72-9. PubMed ID: 11451151
    [Abstract] [Full Text] [Related]

  • 15. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver.
    Takeda K, Cretney E, Hayakawa Y, Ota T, Akiba H, Ogasawara K, Yagita H, Kinoshita K, Okumura K, Smyth MJ.
    Blood; 2005 Mar 01; 105(5):2082-9. PubMed ID: 15536146
    [Abstract] [Full Text] [Related]

  • 16. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors.
    Poggi A, Massaro AM, Negrini S, Contini P, Zocchi MR.
    J Immunol; 2005 Mar 01; 174(5):2653-60. PubMed ID: 15728472
    [Abstract] [Full Text] [Related]

  • 17. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
    Kayagaki N, Yamaguchi N, Nakayama M, Kawasaki A, Akiba H, Okumura K, Yagita H.
    J Immunol; 1999 Mar 01; 162(5):2639-47. PubMed ID: 10072506
    [Abstract] [Full Text] [Related]

  • 18. Death receptors and ligands in cervical carcinogenesis: an immunohistochemical study.
    Reesink-Peters N, Hougardy BM, van den Heuvel FA, Ten Hoor KA, Hollema H, Boezen HM, de Vries EG, de Jong S, van der Zee AG.
    Gynecol Oncol; 2005 Mar 01; 96(3):705-13. PubMed ID: 15721415
    [Abstract] [Full Text] [Related]

  • 19. Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Song JH, Bellail A, Tse MC, Yong VW, Hao C.
    J Neurosci; 2006 Mar 22; 26(12):3299-308. PubMed ID: 16554480
    [Abstract] [Full Text] [Related]

  • 20. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth.
    Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Yamaguchi N, Yagita H, Okumura K.
    Cell Immunol; 2001 Dec 15; 214(2):194-200. PubMed ID: 12088418
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.